Best Stocks To Buy For 2013: GTA.V

[ July 29, 2013 | Author: admin | Views: 20584 | Weather: | Mood: normal]

Value investors tend to favor specific gauges to find bargains. Some like to seek out stocks trading below tangible book value, while others seek out stocks that sport low price-to-earnings (P/E) multiples or impressive free cash flow characteristics. But why not focus on all three gauges? I ran a screen to find stocks that press all the buttons, targeting only companies with a market value above $500 million and 2014 P/E multiples below 12. To preserve a nice margin of error for downside protection, I narrowed the list to stocks trading for less than 95% of tangible book value. Here's what I found. Of course, these numbers are just a starting point, and the seemingly least expensive stocks aren't always the top bargain. Case in point: Century Aluminum (Nasdaq: CENX), which holds a trove of undervalued assets parked on its balance sheet but is struggling to generate profits in an … Continue reading

[ May 15, 2013 | Author: admin | Views: 98547 | Weather: | Mood: normal]

It hasn’t been this bad for months. Apple (NASDAQ: AAPL  ) shares have been utterly crushed today, dramatically underperforming the broader market that’s also selling off in part on soft earnings. While there was a typical chorus of downward revisions among Street analysts, investors should be used to that by now, and those modeling tweaks aren’t likely the primary cause of shares getting taken out to the woodshed. Goldman Sachs warned investors not to expect any dividend announcements until after next week’s earnings release, echoing other analysts in recent memory. The firm also expects Apple’s figures to come in slightly below consensus, and expects “near-term momentum” to “further weaken” ahead of new product launches expected on the horizon. Goldman’s still bullish overall, with a “buy” rating and $575 price target. 10 Best Performing Stocks To Invest In Right Now: Trius Therapeutics Inc.(TSRX) Trius Therapeutics, Inc., a biopharmaceutical company, focuses on the … Continue reading

[ April 15, 2013 | Author: admin | Views: 45528 | Weather: | Mood: normal]

Shares of Monster Beverage (NASDAQ: MNST  ) rose nearly 5% Monday after the company’s board of directors approved a $200 million share repurchase program. As management stated recently, the company had already used every penny of the $250 million it authorized for share repurchases less than five months ago, so it looks like they were just itching to continue increasing shareholders’ slice of the pie. Even so, I suppose this latest authorization shouldn’t have come as much of a surprise considering the company managed to spend more than $737 million in 2012, buying back shares at an average price of $54.47 per share — or about 3% below yesterday’s closing price. Does it make sense?Okay, we get it; the folks at Monster are trying to send investors a not-so-subtle message that they think their stock is undervalued. Hot Undervalued Companies To Own In Right Now: Gta Corpfin Capital Inc (GTA.V) GTA … Continue reading